ENTPD1 and Sepsis: Both septic patients and animals exhibit enhanced accumulation of CD39+ plasmablasts, an important driver of sepsis-induced immunosuppression, which is associated with impaired bacterial killing and poor outcomes (Nascimento et al., 2021; Zhou et al., 2021).